116 related articles for article (PubMed ID: 31957550)
21. Enterocystoplasty vs detrusorectomy: outcome in the adult with spina bifida.
Veenboer PW; Nadorp S; de Jong TP; Dik P; van Asbeck FW; Bosch JL; de Kort LM
J Urol; 2013 Mar; 189(3):1066-70. PubMed ID: 23017520
[TBL] [Abstract][Full Text] [Related]
22. Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study.
Neuzillet Y; Soulie M; Larre S; Roupret M; Defortescu G; Murez T; Pignot G; Descazeaud A; Patard JJ; Bigot P; Salomon L; Colin P; Rigaud J; Bastide C; Durand X; Valeri A; Kleinclauss F; Bruyere F; Pfister C;
BJU Int; 2013 Jun; 111(8):1253-60. PubMed ID: 23331375
[TBL] [Abstract][Full Text] [Related]
23. Bladder adenocarcinoma following gastrocystoplasty.
Zhang X; Gupta R; Nicastri AD
J Pediatr Urol; 2010 Oct; 6(5):525-7. PubMed ID: 20392671
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic signet ring cell carcinoma arising in gastrocystoplasty.
Baydar DE; Allan RW; Castellan M; Labbie A; Epstein JI
Urology; 2005 Jun; 65(6):1226. PubMed ID: 15922432
[TBL] [Abstract][Full Text] [Related]
26. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
[TBL] [Abstract][Full Text] [Related]
27. [Bladder augmentation in childhood and adolescence: beware of risk of cancer on adult patients].
Boillot B;
Prog Urol; 2013 Dec; 23(16):1375-6. PubMed ID: 24274940
[No Abstract] [Full Text] [Related]
28. [Surgical urinary diversion in children from war and crisis areas-20-year experience report].
Kranz J; Dück M; Steffens C; Reisch B; Steffens J
Urologe A; 2018 Oct; 57(10):1208-1213. PubMed ID: 30116832
[TBL] [Abstract][Full Text] [Related]
29. Risk of malignancy after augmentation cystoplasty: A systematic review.
Biardeau X; Chartier-Kastler E; Rouprêt M; Phé V
Neurourol Urodyn; 2016 Aug; 35(6):675-82. PubMed ID: 25867054
[TBL] [Abstract][Full Text] [Related]
30. Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
Shelekhova KV; Krykow KA; Mescherjakov IA; Mitin NP
Int J Surg Pathol; 2019 Aug; 27(5):483-491. PubMed ID: 30854907
[TBL] [Abstract][Full Text] [Related]
31. Bladder adenocarcinoma 41 years after augmentation enterocystoplasty for tuberculosis.
Quinta A; Carvalho AP; Oliveira M; Oliveira C; Ribeiro Santos A
Arch Esp Urol; 2013 Mar; 66(2):231-3. PubMed ID: 23589601
[TBL] [Abstract][Full Text] [Related]
32. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
33. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
34. Long-term followup of patients after redo bladder neck reconstruction for bladder exstrophy complex.
Burki T; Hamid R; Duffy P; Ransley P; Wilcox D; Mushtaq I
J Urol; 2006 Sep; 176(3):1138-41; discussion 1141-2. PubMed ID: 16890709
[TBL] [Abstract][Full Text] [Related]
35. Enterocystoplasty 30-day outcomes from National Surgical Quality Improvement Program Pediatric 2012.
Du K; Mulroy EE; Wallis MC; Zhang C; Presson AP; Cartwright PC
J Pediatr Surg; 2015 Sep; 50(9):1535-9. PubMed ID: 25957024
[TBL] [Abstract][Full Text] [Related]
36. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
[TBL] [Abstract][Full Text] [Related]
37. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
38. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M; Helke C; Nitzke T; Vogler H; Hoschke B
Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
[TBL] [Abstract][Full Text] [Related]
39. [Total cystectomy for urinary bladder cancer: clinicopathological study of 95 cases].
Murase T; Takashi M; Aota Y; Shimoji T; Miyake K; Mitsuya H
Hinyokika Kiyo; 1985 Apr; 31(4):615-21. PubMed ID: 4036737
[TBL] [Abstract][Full Text] [Related]
40. Long-term histological and mucin alterations in the neobladder mucosa following urinary bladder augmentation or substitution with gastrointestinal segment.
Kispal ZF; Kardos D; Jilling T; Kereskai L; Isaacs M; Balogh DL; Pinter AB; Till H; Vajda P
J Pediatr Urol; 2015 Dec; 11(6):349.e1-6. PubMed ID: 26298391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
